The use of GLP-1 drugs to treat obesity has cause awareness of the complex medical condition to surge. But the cost of ...

The same global food system that is fueling rising obesity rates is also accelerating climate change, according to a sweeping ...

Since their introduction, GLP-1 medications have rapidly gained popularity for their effectiveness in helping people manage ...

GLP-1s for weight loss may not affect the risk of obesity-related cancers either way, an analysis of the existing evidence ...

Healthy snacks are in demand as meals are being “swapped for grazing” as the rise of weight-loss jabs encourages a “change in ...

Emil Kongshøj Larsen, Executive Vice President for International Operations at Novo Nordisk, talks to BT about India’s role ...

There is no exact known number of GLP-1 patients who say their say their sense of taste has changed since starting the ...

A global study reveals an alarming rise in gout cases among young people aged 15 to 39, with rates increasing 66% from 1990 ...

The first ‘real-world study’ into the weight loss drug, Mounjaro, has now started in Greater Manchester. Thousands of ...

The implications from the design of the clinical GLP-1 agonist trials and studies of caloric restriction are that exercise is ...

Cases of colorectal cancer in younger adults are climbing worldwide, driven by lifestyle changes and inherited genetic risks.

Novo Nordisk NVO announced the submission of a new drug application (NDA) to the FDA, seeking approval for its ...